1
Epidemiological Study of Methicillin- Resistant Staphylococcus aureus Among Patients in a Burn ICU Bayless Drum, MS2 1 and Pranavi Sreeramoju, MD, MPH 1,2 1. UT Southwestern Medical Center; 2. Department of InfecEon PrevenEon, Parkland Health and Hospital System, Dallas, TX Background Infec’ons caused by an’bio’c resistant bacteria including methicillin resistant Staphylococcus aureus (MRSA) are associated with an increased morbidity and mortality in hospitalized pa’ents. Ac’ve surveillance culture (ASC) programs that involve iden’fying asymptoma’cally colonized pa’ents and placing them on contact precau’ons have been promoted to control the spread of hospitalonset bacterial infec’ons. Burn pa’ents are par’cularly suscep’ble to staphylococcal infec’on, and a complete understanding of the effec’veness of ASCs in preven’ng hospital onset infec’ons among burn pa’ents is limited. The objec’ve of this retrospec’ve observa’onal study is to describe the epidemiology of MRSA among pa’ents in an academic medical center burn unit including the impact of removal of ASCs on hospitalonset (HO) blood stream infec’ons (BSI) in order to inform MRSA control efforts in this popula’on 1980s 2011 2012 2013 2014 ASC Began Start of Study Period FebJun Outbreak ASC Ended FollowUp No ASC Timeline Aim Statement The aim of this project is to retrospec’vely determine the effec’veness of ac’ve surveillance cultures (ASC) in controlling hospitalonset (HO) MRSA bloodstream infec’ons (BSI) in the Burn Intensive and Burn Acute Care Units of Parkland Health and Hospital system by comparing the rate during December 2011August 2014 when ASC were used with the rate during September 2014August 2015 when ASC were discon’nued. This is important in order to understand whether established best prac’ces for MRSA preven’on in the burn popula’on must include ASC. PDSA: ASC IntervenEon • Organize and analyze infec’on rate data. • 1980s ASC Began • How do results affect future prac’ce? ACT PLAN DO STUDY Measures Measures: Admission Surveillance Adherence % screened for colonizaEon in BICU % screened for colonizaEon in BACU ASC period 20.90% 12.50% ASC w/o outbreak period 18.21% 6% outbreak period 82.88% 41.80% Measures: Hospitalonset Blood Stream InfecEons Measures: Communityonset ColonizaEon ColonizaEo n of Admits Range of Monthly Rate ASC period 1.35% 018.75% ASC w/o outbreak period 0.94% 07.32% outbreak period 10.81% 3.8518.75% BICU BACU YES NO End ASC Study BSI rates Did removing ASC increase HO BSI significantly? Recommend to reestablish ASC Recommend to con’nue without ASC ColonizaE on of Admits Range of Monthly Rate ASC period 1.89% 017.1% ASC w/o outbreak period 1% 02.9% outbreak period 5.3% 017.1% Decision Flow Chart Conclusions and Next Steps Team Members Results Removal of the ASC led to an increase in HO BSI that was not sta’s’cally significant. Impact Karla VoyHacer, RN, MPH, MHA, CIC Katherine Collinsworth, MSN Steven Wolf, MD Brec Arnoldo, MD Pranavi Sreeramoju, MD, MPH Recommend con’nuing MRSA preven’on without ASC in Parkland Burn Unit. Monitor BSI rates and focus on other widely accepted infec’on preven’on measures. BICU and BACU Combined BICU BACU ASC period 1.23 2.59 0.31 ASC w/o outbreak period 1.16 2.39 0.36 outbreak period 1.66 3.59 0 follow-up period 1.56 3.72 0.25 HOBSI Incidence (Rate) = Number of HOBSI/ Number of PaEentDays *1000 Rate RaEo (95% Confidence Interval) Pvalue BICU and BACU Combined 1.26 (0.57,2.68) 0.54 BICU 1.43 (0.61, 3.19) 0.39 BACU 0.81 (0.03, 7.57) 0.92 HOBSI Rate: FollowUp Period vs. ASC Period Was there a significant increase in the HOBSI rate from ASC period to followup period? NO

Epidemiological Study of Methicillin- Resistant ......Epidemiological Study of Methicillin-Resistant Staphylococcus aureus Among Patients in a Burn ICU Bayless’Drum,’MS21and’

  • Upload
    others

  • View
    3

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Epidemiological Study of Methicillin- Resistant ......Epidemiological Study of Methicillin-Resistant Staphylococcus aureus Among Patients in a Burn ICU Bayless’Drum,’MS21and’

Epidemiological Study of Methicillin-Resistant Staphylococcus aureus

Among Patients in a Burn ICU Bayless  Drum,  MS21  and  Pranavi  Sreeramoju,  MD,  MPH1,2    

1.  UT  Southwestern  Medical  Center;  2.  Department  of  InfecEon  PrevenEon,  Parkland  Health  and  Hospital  System,  Dallas,  TX  

Background    

Infec'ons  caused  by  an'bio'c  resistant  bacteria  including  methicillin-­‐  resistant  Staphylococcus  aureus  (MRSA)  are  associated  with  an  increased  morbidity  and  mortality  in  hospitalized  pa'ents.  Ac've  surveillance  culture  (ASC)  programs  that  involve  iden'fying  asymptoma'cally  colonized  pa'ents  and  placing  them  on  contact  precau'ons  have  been  promoted  to  control  the  spread  of  hospital-­‐onset  bacterial  infec'ons.  Burn  pa'ents  are  par'cularly  suscep'ble  to  staphylococcal  infec'on,  and  a  complete  understanding  of  the  effec'veness  of  ASCs  in  preven'ng  hospital  onset  infec'ons  among  burn  pa'ents  is  limited.  The  objec've  of  this  retrospec've  observa'onal  study  is  to  describe  the  epidemiology  of  MRSA  among  pa'ents  in  an  academic  medical  center  burn  unit  including  the  impact  of  removal  of  ASCs  on  hospital-­‐onset  (HO)  blood  stream  infec'ons  (BSI)  in  order  to  inform  MRSA  control  efforts  in  this  popula'on  

1980s       2011   2012   2013   2014   2015  

ASC  Began  

Start  of  Study  Period  

Feb-­‐Jun  Outbreak  

ASC  Ended  

Follow-­‐Up  No  ASC  

Timeline  

Aim  Statement  

The  aim  of  this  project  is  to  retrospec'vely  determine  the  effec'veness  of  ac've  surveillance  cultures  (ASC)  in  controlling  hospital-­‐onset  (HO)  MRSA  bloodstream  infec'ons  (BSI)  in  the  Burn  Intensive  and  Burn  Acute  Care  Units  of  Parkland  Health  and  Hospital  system  by  comparing  the  rate  during  December  2011-­‐August  2014  when  ASC  were  used  with  the  rate  during  September  2014-­‐August  2015  when  ASC  were  discon'nued.      This  is  important  in  order  to  understand  whether  established  best  prac'ces  for  MRSA  preven'on  in  the  burn  popula'on  must  include  ASC.  

PDSA:  ASC  IntervenEon  

• Organize  and        analyze  infec'on        rate  data.  

• 1980s  ASC  Began  

• How  do  results  affect  future  prac'ce?  

ACT   PLAN  

DO  STUDY  

   

Measures  

Measures:  Admission  Surveillance  Adherence  

   

%  screened  for  colonizaEon  in  BICU  

 %  screened  for  colonizaEon  in  BACU  

ASC  period   20.90%   12.50%  ASC  w/o  outbreak  period   18.21%   6%  outbreak  period   82.88%   41.80%  

Measures:  Hospital-­‐onset  Blood  Stream  InfecEons  

Measures:  Community-­‐onset    ColonizaEon  

   ColonizaEon  of  Admits  

Range  of  Monthly  Rate    

ASC  period   1.35%   0-­‐18.75%  ASC  w/o  outbreak  period   0.94%   0-­‐7.32%  outbreak  period   10.81%  3.85-­‐18.75%  

BICU   BACU  

YES  

NO  

End  ASC   Study  BSI  rates  

Did  removing  ASC  increase  HO  

BSI  significantly?  

Recommend  to  reestablish  ASC  

Recommend  to  con'nue  without  

ASC  

   

ColonizaEon  of  Admits  

Range  of  Monthly  Rate    

ASC  period   1.89%   0-­‐17.1%  ASC  w/o  outbreak  period   1%   0-­‐2.9%  outbreak  period   5.3%   0-­‐17.1%  

Decision  Flow  Chart  

 

 

Conclusions  and  Next  Steps  

Team  Members  

Results  Removal  of  the  ASC  led  to  an  increase  in  HO  BSI  that  was  not  sta's'cally  significant.    

   

Impact  

Karla  Voy-­‐Hacer,  RN,  MPH,  MHA,  CIC  Katherine  Collinsworth,  MSN  Steven  Wolf,  MD  Brec  Arnoldo,  MD  Pranavi  Sreeramoju,  MD,  MPH    

Recommend  con'nuing  MRSA  preven'on  without  ASC  in  Parkland  Burn  Unit.  Monitor  BSI  rates  and  focus  on  other  widely  accepted  infec'on  preven'on  measures.    

   

BICU and BACU Combined BICU BACU

ASC period 1.23 2.59 0.31 ASC w/o outbreak period 1.16 2.39 0.36 outbreak period 1.66 3.59 0 follow-up period 1.56 3.72 0.25

HO-­‐BSI  Incidence  (Rate)  =    Number  of  HO-­‐BSI/  Number  of  PaEent-­‐Days  *1000  

   

   

Rate  RaEo  (95%  Confidence  Interval)   P-­‐value  

BICU  and  BACU  Combined  

1.26  (0.57,2.68)   0.54    

BICU  

1.43    (0.61,  3.19)   0.39  

BACU  

0.81    (0.03,  7.57)   0.92  

HO-­‐BSI  Rate:  Follow-­‐Up  Period  vs.  ASC  Period  

Was  there  a  significant    increase  in  the  HO-­‐BSI  rate  from  ASC    period  to  follow-­‐up  period?    NO